IGF::OT::IGF

Information

• Research Project
• 9568964

• ApplicationId

  9568964

• Core Project Number

  N02CA000000

• Full Project Number

  261201500009I-0-26100021-1

• Serial Number

• FOA Number

• Sub Project Id

• Project Start Date

  4/14/2017 - 7 years ago

• Project End Date

  10/14/2017 - 7 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2017

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• IRISYS, INC.

The Contractor will manufacture 1,000 hard gelatin capsules containing one to five (1-5) mg Aza-Td-Cyd (most likely higher than 1 mg) under cGMP condition for clinical use (The actual dose will be provided by the Project Officer upon sending API) . The formulation will be similar to 10 mg TD-Cyd capsules to fill a size 4 capsule, which color should be other than Swedish Orange. After QC release, testing please place 10 capsules per suitable size container and after inserting a pharmaceutical coil seal the container with induction sealer.

IC Name

• Activity

  N02

• Administering IC

  CA

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  82758

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

• Ed Inst. Type

• Funding ICs

  NCI:82758\

• Funding Mechanism

  Non SBIR/STTR Contracts

• Study Section

• Study Section Name

• Organization Name

  IRISYS, INC.

• Organization Department

• Organization DUNS

  079682716

• Organization City

  SAN DIEGO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  92121

• Organization District

  UNITED STATES